Currently, over 300 million people worldwide have depression, and the socioeconomic
burden of this debilitating disorder is anticipated to increase markedly over the coming …

Depression is a highly prevalent risk factor for incident coronary heart disease (CHD) and for
cardiovascular morbidity and mortality in patients with established CHD. Several biological …

Objective: To provide expert recommendations for the safe and effective application of
repetitive transcranial magnetic stimulation (rTMS) in the treatment of major depressive …

Abstract Purpose of Review The aim of this review article was to summarize recent
publications on effects of antidepressants on sleep and to show that these effects not only …

Depression is a debilitating condition with a profound impact on quality of life for millions of
people worldwide. Physical exercise is used as a treatment strategy for many patients, but …

Anhedonia is one of the core symptoms of major depressive disorder (MDD), which is often
inadequately treated by traditional antidepressants. The modern framework of anhedonia …

Purpose We aimed to systematically review recent publications (01/2014–03/2017) with
longitudinal designs allowing for the assessment of the prospective risk of insomnia on new …

Depression has been shown to negatively impact neurocognitive functions, particularly
those governed by fronto-subcortical networks, such as executive functions. Converging …

We describe evidence for dissociable roles of the medial and lateral orbitofrontal cortex
(OFC) in major depressive disorder (MDD) from structure, functional activation, functional …

Our behavior is constantly accompanied by a sense of confidence and its' precision is critical
for adequate adaptation and survival. Importantly, abnormal confidence judgments that do …